Government SI Register · VA · High impact

Screen for Esophageal Adenocarcinoma

The Department of Veterans Affairs lists "Screen for Esophageal Adenocarcinoma" in the 2025 federal inventory as a high impact SI use case at the pilot stage, in VHA: Veterans Health Administration. In the agency's words, the problem it is meant to solve: "Veterans disproportionately have many of the important risk factors for esophageal adenocarcinoma (EAC), and research has demonstrated that Veterans are a substantial gap in the prevention of EAC. Healthcare providers can utilize Kettles Esophageal and Cardia Adenocarcinoma prediction tool (K-ECAN) to guide decision-making and identify potential patients who should be offered screening for EAC." Every field below is quoted as filed.

ID VA-25-5375Stage PilotSource row 3437

The record, as filed

Every field the agency reported

Bureau or component
VHA: Veterans Health Administration
Stage
Pilot
High impact status
High-impact
Topic area
Health and Medical
Technology type
Classical ML
Problem it is meant to solve
Veterans disproportionately have many of the important risk factors for esophageal adenocarcinoma (EAC), and research has demonstrated that Veterans are a substantial gap in the prevention of EAC. Healthcare providers can utilize Kettles Esophageal and Cardia Adenocarcinoma prediction tool (K-ECAN) to guide decision-making and identify potential patients who should be offered screening for EAC.
Expected benefits
If EAC is identified at the earliest stage (intramucosal cancer without metastases), the 5-year survival with surgery is greater than 85%, and at least as good with endoscopic therapy alone. Implementation of such an intervention would bridge the gap between population-health screenings and personalized management in a manner that would minimize the impact on payer budget and resources. Since individuals are more commonly up to date for colorectal cancer screening (for instance, with colonoscopy), it is particularly suitable to harness the missed opportunity of EAC screening at the time of screening for colorectal cancer. Also, when an EAC screening with upper endoscopy is performed simultaneously with colonoscopy, it is much less expensive. This project will also serve as a roadmap for how such precision approaches to screening can be applied to other rare cancers.
What the system outputs
The K-ECAN is an automated prediction tool for EAC that harnesses the electronic health record at the point of contact during opportune moments (such as at the time of scheduling colorectal cancer screening) to guide decision-making and identify patients who should be offered screenings for EAC. The provider would know their patient's predicted annual incidence of EAC or esophagogastric junction adenocarcinoma (EGJAC) (at least [XXX per 100,000) and their predicted annual mortality (at least [YYY] per 100,000). They would also know additional risk factors, such as age, sex, Body Mass Index (BMI), Gastroesophageal reflux disease (GERD), and smoking history.
How it was built or bought
In-house Development
Custom-developed code
Yes
Public source code
https://osf.io/tvu8z/?view_only=0f912ec4a63d410abac4943426bc92f2

Left blank in the record: Justification given, Operational or pilot start, Vendors, Authorization to Operate, System name, Data used to train, tune or evaluate, Federal Data Catalog link, Uses personally identifiable information, Privacy Impact Assessment, Demographic features used, Pre-deployment testing, Impact assessment completed, Potential impacts identified, Independent review, Ongoing monitoring, Operator training, Fail-safe, Appeal process, Consultation with users and the public. Point of contact details are in the source file.

Source

Source: row 3437 of 2025_individually_reported_AI_use_cases.csv in OMB's 2025 Federal Agency AI Use Case Inventory repository (summary as of April 13, 2026), read Nov 17, 2026. File SHA-256 a62721202ca4b110

Life areas: Health and medicine, Veterans.

Records, not ratings. Every entry is what an agency reported to OMB, quoted as filed. The register does not test, rate or vouch for any system, and a record does not prove how a system is used day to day.